Anesthesiology and Pulmonary Medicine
Measles outbreak underscores need for continued vigilance in health care settings
April 28, 2011 8:35 pm | by EurekAlert | News | Comments(Infectious Diseases Society of America) In 2008, the largest reported health care-associated measles outbreak in the United States since 1989 occurred in Tucson, Ariz., costing approximately $800,000 in response and containment efforts. In a report published in The Journal of Infectious...
Frequently hospitalized patients may benefit from new medical specialty focused on their needs
April 28, 2011 8:35 pm | by EurekAlert | News | Comments(University of Chicago) Declining rates of hospitalization have discouraged primary care doctors from seeing their patients in the hospital and encouraged the growing use of "hospitalists," a new physician specialty focused on the care of hospitalized patients. Further developments in the...
Use of costly breast cancer therapy strongly influenced by reimbursement policy
April 28, 2011 11:33 am | by EurekAlert | News | Comments(Journal of the National Cancer Institute) What Medicare would pay for and where a radiation oncologist practiced were two factors that strongly influenced the choice of intensity-modulated radiation therapy (IMRT) for treating breast cancer, according to an article published April 29...
MAQUET Cardiovascular Receives 510(k) Clearance to Market the CARDIOHELP System in U.S.
April 28, 2011 6:35 am | by Bio-Medicine.Org | News | CommentsWAYNE, N.J., April 28, 2011 /- MAQUET Cardiovascular today announced that the U.S. Food and Drug Administration has granted the company 510(k) clearance to market its CARDIOHELP System in the United States as a cardiac and/or respiratory assist device for up to six hours. The...
International Leaders in Electrophysiology Discuss Improving Atrial Fibrillation Treatment Using Novel Endoscopically Guided Laser Ablation Catheter
April 28, 2011 2:33 am | by Bio-Medicine.Org | News | CommentsMARLBOROUGH, Mass., April 28, 2011 /- CardioFocus, Inc., developer of the Endoscopic Ablation System for the transcatheter treatment of Atrial Fibrillation (AF), convened international leaders in electrophysiology to discuss the advantages of direct optical visualization to guide catheter...
Large differences in mortality between urban and isolated rural areas
April 27, 2011 11:34 am | by EurekAlert | News | Comments(Norwegian Institute of Public Health) In urban communities, less than 1 in 100 inhabitants died from Spanish flu in 1918, but in isolated communities up to 9 out of 10 died. This could be due to different exposure to influenza in the decades before Spanish flu. People in urban...
Less than One-Third of Patients Taking Montelukast (Singulair®) Therapy for Asthma or Allergies without Trying First-Line Medications End Up Staying on the Medication
April 27, 2011 6:34 am | by Bio-Medicine.Org | News | CommentsST. PAUL, Minn., April 27, 2011 /- Patients with asthma or allergic rhinitis (nasal allergies), initially prescribed montelukast (Singulair®) instead of typical first-line therapy have low rates of persistence on montelukast and may ultimately discontinue therapy altogether,...
Advanced Life Sciences Ticker Symbol Reverts Back to 'ADLS.OB'
April 27, 2011 6:34 am | by Bio-Medicine.Org | News | CommentsCHICAGO, April 27, 2011 /- Advanced Life Sciences Holdings, Inc. (OTC Bulletin Board: ADLS.OB) , a biopharmaceutical company engaged in the discovery, development and commercialization of novel drugs in the therapeutic areas of infection, oncology and respiratory diseases, announced that...
Reportlinker Adds Global Cardiovascular Surgery Devices Market Trends and Future Forecast (2009 - 2014)
April 27, 2011 5:34 am | by Bio-Medicine.Org | News | CommentsNEW YORK, April 27, 2011 /- Reportlinker.com announces that a new market research report is available in its catalogue: Global Cardiovascular Surgery Devices Market Trends and Future Forecast (2009 - 2014)...
Dehaier Medical to Report First Quarter 2011 Financial Results on May 4
April 27, 2011 3:34 am | by Bio-Medicine.Org | News | CommentsBEIJING, April 27, 2011 /PRNewswire-Asia-FirstCall/ -- Dehaier Medical Systems Ltd. (Nasdaq: DHRM ) ("Dehaier" or the "Company"), an emerging leader in the development, assembly, marketing and sale of medical devices and homecare medical products in China, today announced that it will...
Renewable Fuel Standard Provides Market Space and Predictable Price for Advanced Biofuels
April 26, 2011 5:34 pm | by Biotechnology Industry Organization | News | CommentsWASHINGTON, D.C. (Tuesday, April 19, 2011) - The federal Renewable Fuel Standard provides the stable market support and pricing system necessary to attract private investment to the development of advanced biofuels, according to a new policy white paper published by the Biotechnology...
Mosby's eLearning and the ASHI introduce ACLS Blended Learning Solution
April 26, 2011 5:34 pm | by EurekAlert | News | Comments(Elsevier) Mosby's eLearning, a pioneer in providing eLearning solutions to more than 1,300 healthcare organizations, and the American Safety & Health Institute (ASHI) today introduced the Advanced Cardiac Life Support (ACLS) Blended Learning Solution, a training certification solution...
Central European Society for Anticancer Drug Research Announces Start of Enrollment in First Randomized Trial of Pharmacokinetic-Guided Dose Adjustment of Paclitaxel in Non-Sm...
April 26, 2011 5:34 pm | by Bio-Medicine.Org | News | CommentsVIENNA and BETHLEHEM, Pa., April 26, 2011 /- In collaboration with Saladax Biomedical, Inc., the Central European Society for Anticancer Drug Research (CESAR) announced today that enrollment has begun in the CEPAC-TDM trial of paclitaxel therapeutic drug management (TDM) with subsequent...
Accuray Incorporated Announces HSR Clearance in Acquisition of TomoTherapy
April 26, 2011 4:35 am | by Bio-Medicine.Org | News | CommentsSUNNYVALE, Calif., April 26, 2011 /- Accuray Incorporated (Nasdaq: ARAY ), a global leader in the field of radiosurgery, today announced the expiration of the mandatory, pre-merger waiting period under the Hart-Scott-Rodino (HSR) Antitrust Improvements Act of 1976, in connection with the...
Racial differences in willingness to exhaust personal finances for life-sustaining care
April 25, 2011 8:35 pm | by EurekAlert | News | Comments(Wiley-Blackwell) Minority races -- especially blacks -- are more willing than whites to expend personal financial resources to prolong life after being diagnosed with lung or colorectal cancer, even if it means using up all of their personal financial resources. That is the conclusion of...
Blacks more willing to exhaust financial resources for more cancer care
April 25, 2011 8:34 pm | by EurekAlert | News | Comments(University of Alabama at Birmingham) Blacks, Hispanics and Asians are more likely than whites to spend their life savings to extend life; preferences could inform cancer care
Pharmacists Offer Guidance on Top Over-The-Counter Medications
April 25, 2011 7:33 am | by Bio-Medicine.Org | News | CommentsWASHINGTON, April 25, 2011 /PRNewswire-USNewswire/ -- The 2010 Pharmacy Today Over-the-Counter Product Survey , conducted by the American Pharmacists Association , reveals pharmacists believe that 81% of consumers purchase the over-the-counter (OTC) product that was recommended by their...
Mylan Launches First Generic Version of Femara® Tablets
April 25, 2011 5:33 am | by Bio-Medicine.Org | News | CommentsPITTSBURGH, April 25, 2011 /- Mylan Inc. (Nasdaq: MYL ) today announced that its subsidiary Mylan Pharmaceuticals Inc. has launched Letrozole Tablets USP, 2.5 mg, under a previously announced settlement and license agreement with Novartis. Mylan was the first company to have filed a...
Stephen Maturo, M.D., ear, nose and throat specialist, receives Charles Ferguson Award
April 24, 2011 9:33 pm | by EurekAlert | News | Comments(American Academy of Otolaryngology - Head and Neck Surgery) Stephen Maturo, M.D., of Boston, Mass., will receive the first place Charles Ferguson Clinical Science Award for outstanding achievement in the field of pediatric otolaryngology for his research paper titled "Intraoperative...
Combination therapy provides hope for cure of dangerous infections of cystic fibrosis patients(2)
April 24, 2011 10:34 am | by EurekAlert | News | Comments(McMaster University) An over-the-counter drug used to treat diarrhea combined with minocycline, an antibiotic used to treat bacterial infections, could one day change the lives of those living with cystic fibrosis.
Brown & Toland Makes "Best Places to Work" List for Second Year in a Row
April 22, 2011 11:33 am | by Bio-Medicine.Org | News | CommentsSAN FRANCISCO, April 22, 2011 /- Brown & Toland Physicians was named one of the 50 Best Places to Work in the San Francisco Bay Area for 2011. This is the second year in a row that the physician group has earned this prestigious recognition. (Logo:...
New approach to defeating flu shows promise
April 21, 2011 9:35 pm | by EurekAlert | News | Comments(American Thoracic Society) New research on mice has shown that pulmonary administration of granulocyte macrophage-colony stimulating factor (GM-CSF) significantly reduces flu symptoms and prevents death after a lethal dose influenza virus. While GM-SCF therapy for humans as a flu...
Scott & White Healthcare Broadcasts Live Surgery to Sao Paolo, Brazil
April 21, 2011 8:35 am | by Bio-Medicine.Org | News | CommentsTEMPLE, Texas, April 21, 2011 /- Scott & White Healthcare today teleconferenced one of the world's first live international surgical procedures to repair an abdominal aortic aneurysm to conference attendees in Sao Paolo, Brazil. The meeting, CICE (Current Issues in Comparative...
Cancer Centers of North Carolina Acquires Wake Radiology Oncology Services of Cary, N.C.
April 20, 2011 8:34 am | by Bio-Medicine.Org | News | CommentsCARY, N.C. and THE WOODLANDS, Texas, April 20, 2011 /- Cancer Centers of North Carolina (CCNC), an affiliate of the United Network of US Oncology and the first practice to offer community-based outpatient cancer care in the Triangle with locations in Raleigh, North Raleigh, Cary, Dunn and...
Mylan Launches Generic Version of Famvir® Tablets
April 20, 2011 5:34 am | by Bio-Medicine.Org | News | CommentsPITTSBURGH, April 20, 2011 /- Mylan Inc. (Nasdaq: MYL ) today announced that its subsidiary Mylan Pharmaceuticals Inc. has launched Famciclovir Tablets, 125 mg, 250 mg and 500 mg, the generic version of Novartis' Famvir® Tablets, a treatment for herpes. Famciclovir Tablets had...
